Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Consolidated Net Income (2016 - 2024)

Historic Consolidated Net Income for Arcadia Biosciences (RKDA) over the last 11 years, with Q4 2024 value amounting to -$27000.0.

  • Arcadia Biosciences' Consolidated Net Income rose 9875.63% to -$27000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$27000.0, marking a year-over-year increase of 9944.51%. This contributed to the annual value of -$2.7 million for FY2024, which is 6527.57% up from last year.
  • Latest data reveals that Arcadia Biosciences reported Consolidated Net Income of -$27000.0 as of Q4 2024, which was up 9875.63% from -$430000.0 recorded in Q3 2024.
  • Arcadia Biosciences' 5-year Consolidated Net Income high stood at $7.6 million for Q4 2020, and its period low was -$13.8 million during Q4 2021.
  • Over the past 5 years, Arcadia Biosciences' median Consolidated Net Income value was -$2.1 million (recorded in 2023), while the average stood at -$3.5 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first skyrocketed by 22027.56% in 2020, then crashed by 71546.96% in 2024.
  • Over the past 5 years, Arcadia Biosciences' Consolidated Net Income (Quarter) stood at $7.6 million in 2020, then plummeted by 281.77% to -$13.8 million in 2021, then surged by 91.68% to -$1.1 million in 2022, then crashed by 89.11% to -$2.2 million in 2023, then soared by 98.76% to -$27000.0 in 2024.
  • Its last three reported values are -$27000.0 in Q4 2024, -$430000.0 for Q3 2024, and -$789000.0 during Q2 2024.